JP2023541669A5 - - Google Patents
Info
- Publication number
- JP2023541669A5 JP2023541669A5 JP2023517697A JP2023517697A JP2023541669A5 JP 2023541669 A5 JP2023541669 A5 JP 2023541669A5 JP 2023517697 A JP2023517697 A JP 2023517697A JP 2023517697 A JP2023517697 A JP 2023517697A JP 2023541669 A5 JP2023541669 A5 JP 2023541669A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- item
- linker
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063079806P | 2020-09-17 | 2020-09-17 | |
| US63/079,806 | 2020-09-17 | ||
| PCT/US2021/033180 WO2022060424A1 (en) | 2020-09-17 | 2021-05-19 | β-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541669A JP2023541669A (ja) | 2023-10-03 |
| JP2023541669A5 true JP2023541669A5 (https=) | 2024-05-28 |
Family
ID=80776325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517697A Pending JP2023541669A (ja) | 2020-09-17 | 2021-05-19 | アルツハイマー病の処置のためのβ－アミロイドワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230364210A1 (https=) |
| EP (1) | EP4213942A4 (https=) |
| JP (1) | JP2023541669A (https=) |
| KR (1) | KR20230087495A (https=) |
| CN (1) | CN116724046A (https=) |
| AR (1) | AR122127A1 (https=) |
| AU (1) | AU2021345451A1 (https=) |
| CA (1) | CA3192383A1 (https=) |
| IL (1) | IL301223A (https=) |
| MX (1) | MX2023003009A (https=) |
| TW (1) | TW202212348A (https=) |
| WO (1) | WO2022060424A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| USRE50630E1 (en) | 2017-10-31 | 2025-10-14 | Creative BioPeptides, Inc. | Use of an all-D-pentapeptide chemokine antagonist to reduce opioid dose in a person with pain |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| US11510961B2 (en) | 2019-12-19 | 2022-11-29 | Creative Bio-Peptides, Inc. | Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| EP4661891A2 (en) * | 2023-02-06 | 2025-12-17 | Creative Bio-Peptides Inc. | Peptides for treating neurological disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840838A (en) * | 1996-02-29 | 1998-11-24 | University Of Kentucky Research Foundation | Process for enhancing the activity of amyloid β peptides |
| US8173127B2 (en) * | 1997-04-09 | 2012-05-08 | Intellect Neurosciences, Inc. | Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof |
| US7264810B2 (en) * | 2001-01-19 | 2007-09-04 | Cytos Biotechnology Ag | Molecular antigen array |
| AT506819B1 (de) * | 2008-06-12 | 2011-06-15 | Affiris Forschungs Und Entwicklungs Gmbh | Vakzin zur behandlung von alzheimer-krankheit |
| GB201113570D0 (en) * | 2011-08-05 | 2011-09-21 | Glaxosmithkline Biolog Sa | Vaccine |
| US12304935B2 (en) * | 2016-07-29 | 2025-05-20 | Juno Therapeutics, Inc. | Immunomodulatory polypeptides and related compositions and methods |
| BR112022023366A2 (pt) * | 2020-05-19 | 2023-05-02 | Othair Prothena Ltd | Vacina com múltiplos epítopos para o tratamento de mal de alzheimer |
-
2021
- 2021-05-19 US US18/245,523 patent/US20230364210A1/en active Pending
- 2021-05-19 TW TW110118154A patent/TW202212348A/zh unknown
- 2021-05-19 AR ARP210101370A patent/AR122127A1/es unknown
- 2021-05-19 CA CA3192383A patent/CA3192383A1/en active Pending
- 2021-05-19 JP JP2023517697A patent/JP2023541669A/ja active Pending
- 2021-05-19 AU AU2021345451A patent/AU2021345451A1/en active Pending
- 2021-05-19 EP EP21869919.7A patent/EP4213942A4/en active Pending
- 2021-05-19 CN CN202180063988.4A patent/CN116724046A/zh active Pending
- 2021-05-19 MX MX2023003009A patent/MX2023003009A/es unknown
- 2021-05-19 WO PCT/US2021/033180 patent/WO2022060424A1/en not_active Ceased
- 2021-05-19 IL IL301223A patent/IL301223A/en unknown
- 2021-05-19 KR KR1020237012808A patent/KR20230087495A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541669A5 (https=) | ||
| JP2023526500A5 (https=) | ||
| US12178867B2 (en) | MHC class i associated peptides for prevention and treatment of multiple flavi virus | |
| TWI379839B (en) | Aβ immunogenic peptide carrier conjugates and methods of producing same | |
| JP2023541670A5 (https=) | ||
| Moyle et al. | Self-adjuvanting lipopeptide vaccines | |
| US4474757A (en) | Synthetic vaccine and process for producing same | |
| JP2023536746A5 (https=) | ||
| JP2023536995A5 (https=) | ||
| JPH09505559A (ja) | 万能ｄｒ−結合性ペプチドを用いる免疫応答の改変 | |
| JP2002528515A (ja) | 多成分髄膜炎菌ワクチン | |
| JP2011529084A5 (https=) | ||
| US20090123488A1 (en) | Compositions and methods for the treatment and prophylaxis of Alzheimer's disease | |
| US20030175285A1 (en) | Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid | |
| US20120282292A1 (en) | Methods and compositions related to immunogenic fibrils | |
| CA2186595A1 (en) | Synthetic peptide based immunogens for the treatment of allergy | |
| JP2023541671A5 (https=) | ||
| JP2017501990A (ja) | 肺炎連鎖球菌（Ｓ．ｐｎｅｕｍｏｎｉａｅ）に対して防御的なプロリンリッチペプチド | |
| US12409215B2 (en) | Vaccine compositions | |
| JP6352251B2 (ja) | Ｃｒｍ１９７担体タンパク質に結合したｈｉｖｇｐ４１ペプチドを含む免疫原性化合物 | |
| US20230129352A1 (en) | Mhc class i associated peptides for prevention and treatment of zika virus | |
| Valmori et al. | Induction of a cytotoxic T cell response by co‐injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): Further enhancement by pre‐injection of IFA alone | |
| US20050049197A1 (en) | Induction of immune response against desired determinants | |
| JPH05505188A (ja) | 合成ポリペプチド | |
| KR20220062080A (ko) | 전립선암 치료를 위한 면역요법 |